Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Novel Combinatorial Therapeutic Options in NEAT1-Depleted Multiple Myeloma Cells By the Integration of in Vitro and in silico Drug Screening Approaches

Noemi Puccio, Elisa Taiana, Gloria Manzotti, Elisabetta Mereu, Domenica Ronchetti, Cecilia Bandini, Ilaria Craparotta, Laura Di Rito, Marco Bolis, Veronica Manicardi, Valentina Fragliasso, Nicola Amodio, Niccolò Bolli, Stefano Luminari, Alessia Ciarrocchi, Roberto Piva, Antonino Neri

Blood (2023) 142 (Supplement 1): 6612.

https://doi.org/10.1182/blood-2023-190131

Published: 2023

Journal Articles

Selective STAT3 Degraders Dissect Peripheral T-Cell Lymphomas Vulnerabilities Empowering Personalized Regimens

Blood (2021) 138 (Supplement 1): 865.

https://doi.org/10.1182/blood-2021-153995

Published: 2021

Journal Articles

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies

Elisa Bergaggio, Chiara Riganti, Giulia Garaffo, Nicoletta Vitale, Elisabetta Mereu, Cecilia Bandini, Elisa Pellegrino, Verdiana Pullano, Paola Omedè, Katia Todoerti, Luciano Cascione, Valentina Audrito, Anna Riccio, Antonio Rossi, Francesco Bertoni, Silvia Deaglio, Antonino Neri, Antonio Palumbo, Roberto Piva

Blood (2019) 133 (2): 156–167.

https://doi.org/10.1182/blood-2018-05-850826

Published: 2019

Includes: Supplemental data

Journal Articles

A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes

Blood (2017) 130 (Supplement 1): 3997.

https://doi.org/10.1182/blood.V130.Suppl_1.3997.3997

Published: 2017

Journal Articles

Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Tumor Suppressor Gene DUSP22

Blood (2016) 128 (22): 969.

https://doi.org/10.1182/blood.V128.22.969.969

Published: 2016

Journal Articles

Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components

Blood (2016) 128 (22): 4098.

https://doi.org/10.1182/blood.V128.22.4098.4098

Published: 2016

Journal Articles

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Blood (2016) 127 (2): 221–232.

https://doi.org/10.1182/blood-2014-12-614503

Published: 2016

Includes: Supplemental data

Journal Articles

Identification of a New Subclass of ALK Negative Anaplastic Large Cell Lymphoma Expressing Aberrant Levels of ERBB4 Transcripts

Irene Scarfò, Elisa Pellegrino, Ivo Kwee, Luca Agnelli, Elisabetta Mereu, Elisa Bergaggio, Francesco Abate, Rodolfo Machiorlatti, Katia Messana, Andrea Rinaldi, Enrico Tiacci, Sara Serra, Silvia Deaglio, Antonino Neri, Brunangelo Falini, Raul Rabadan, Francesco Bertoni, Giorgio Inghirami, MD, Roberto Piva

Blood (2014) 124 (21): 1679.

https://doi.org/10.1182/blood.V124.21.1679.1679

Published: 2014

Journal Articles

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Blood (2013) 122 (15): 2683–2693.

https://doi.org/10.1182/blood-2013-04-497933

Published: 2013

Includes: Supplemental data

Journal Articles

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Paola Bonetti, Monica Testoni, Marta Scandurra, Maurilio Ponzoni, Roberto Piva, Afua A. Mensah, Andrea Rinaldi, Ivo Kwee, Maria Grazia Tibiletti, Javeed Iqbal, Timothy C. Greiner, Wing-Chung Chan, Gianluca Gaidano, Miguel A. Piris, Franco Cavalli, Emanuele Zucca, Giorgio Inghirami, Francesco Bertoni

Blood (2013) 122 (13): 2233–2241.

https://doi.org/10.1182/blood-2013-01-475772

Published: 2013

Includes: Supplemental data

Journal Articles

microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma

Blood (2013) 122 (12): 2083–2092.

https://doi.org/10.1182/blood-2012-08-447375

Published: 2013

Includes: Supplemental data

Journal Articles

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

Luca Agnelli, Elisabetta Mereu, Elisa Pellegrino, Tania Limongi, Ivo Kwee, Elisa Bergaggio, Maurilio Ponzoni, Alberto Zamò, Javeed Iqbal, Pier Paolo Piccaluga, Antonino Neri, Wing C. Chan, Stefano Pileri, Francesco Bertoni, Giorgio Inghirami, Roberto Piva

Blood (2012) 120 (6): 1274–1281.

https://doi.org/10.1182/blood-2012-01-405555

Published: 2012

Includes: Supplemental data

Journal Articles

BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL)

Blood (2011) 118 (21): 2634.

https://doi.org/10.1182/blood.V118.21.2634.2634

Published: 2011

Journal Articles

Recurrent 11q24.3 Gain Contributes to the Pathogenesis of Diffuse Large B Cell Lymphoma (DLBCL) by Deregulating ETS1 and FLI1

Paola Bonetti, Monica Testoni, Marta Scandurra, Maurilio Ponzoni, MD, Roberto Piva, Afua Adjeiwaa Mensah, Maria Grazia Tibiletti, Ivo Kwee, Timothy C. Greiner, MD, Wing C. Chan, MD, Gianluca Gaidano, Miguel Piris, MD, Emanuele Zucca, MD, Francesco Bertoni, MD

Blood (2011) 118 (21): 1386.

https://doi.org/10.1182/blood.V118.21.1386.1386

Published: 2011

Journal Articles

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Blood (2008) 111 (5): 2765–2775.

https://doi.org/10.1182/blood-2007-07-100651

Published: 2008

Journal Articles

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

Roberto Piva, Roberto Chiarle, Andrea D. Manazza, Riccardo Taulli, William Simmons, Chiara Ambrogio, Valentina D'Escamard, Elisa Pellegrino, Carola Ponzetto, Giorgio Palestro, Giorgio Inghirami

Blood (2006) 107 (2): 689–697.

https://doi.org/10.1182/blood-2005-05-2125

Published: 2006

Journal Articles

p130Cas mediates the transforming properties of the anaplastic lymphoma kinase

Chiara Ambrogio, Claudia Voena, Andrea D. Manazza, Roberto Piva, Ludovica Riera, Laura Barberis, Carlotta Costa, Guido Tarone, Paola Defilippi, Emilio Hirsch, Elisabetta Boeri Erba, Shabaz Mohammed, Ole N. Jensen, Giorgio Palestro, Giorgio Inghirami, Roberto Chiarle

Blood (2005) 106 (12): 3907–3916.

https://doi.org/10.1182/blood-2005-03-1204

Published: 2005

Journal Articles

15-Deoxy-Δ 12,14 -prostaglandin J 2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins

Roberto Piva, Patrizia Gianferretti, Alessandra Ciucci, Riccardo Taulli, Giuseppe Belardo, M. Gabriella Santoro

Blood (2005) 105 (4): 1750–1758.

https://doi.org/10.1182/blood-2004-04-1360

Published: 2005

Journal Articles

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors

Roberto Chiarle, Jerald Z. Gong, Ilaria Guasparri, Anna Pesci, Jonjing Cai, Jian Liu, William J. Simmons, Girish Dhall, Jennifer Howes, Roberto Piva, Giorgio Inghirami

Blood (2003) 101 (5): 1919–1927.

https://doi.org/10.1182/blood-2002-05-1343

Published: 2003

NARROW

Novel Combinatorial Therapeutic Options in NEAT1-Depleted Multiple Myeloma Cells By the Integration of in Vitro and in silico Drug Screening Approaches

Selective STAT3 Degraders Dissect Peripheral T-Cell Lymphomas Vulnerabilities Empowering Personalized Regimens

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies

A Compendium of Transcriptional and Mutational Data to Improve the Stratification of Peripheral T-Cell Lymphoma Subtypes

Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Tumor Suppressor Gene DUSP22

Peripheral T-Cell Lymphomas Not Otherwise Specified: Potential Novel Molecular Entities Based on Both Tumor and Microenvironment Cellular Components

Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts

Identification of a New Subclass of ALK Negative Anaplastic Large Cell Lymphoma Expressing Aberrant Levels of ERBB4 Transcripts

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL)

Recurrent 11q24.3 Gain Contributes to the Pathogenesis of Diffuse Large B Cell Lymphoma (DLBCL) by Deregulating ETS1 and FLI1

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

p130Cas mediates the transforming properties of the anaplastic lymphoma kinase

15-Deoxy-Δ 12,14 -prostaglandin J 2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only